Trial intelligence / Profile preview

Methylphenidate effects on decision-making and cerebral perfusion in adults with ADHD

2012-005246-38Phase 4Completed

Sponsor
University of Oslo
Start
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by University of Oslo. Started Feb 2013; status: completed.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on 2012-005246-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-005246-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call